Biomarkers Beyond Sequencing: Guiding DDR-Targeted Therapy With PET Imaging

Time: 11:30 am
day: Day Two


  • PET molecular imaging as a tool to guide targeted precision cancer therapy
  • Assessing PARP-1 expression and PARPi pharmacology with radioligand PARPi analogs
  • Pre-clinical and early clinical results demonstrating the utility of PET PARP imaging for patient selection and drug dosing